Pubblicazioni

The use of anthracycline at first-line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma. The REFOLL study by the Fondazione Italiana Linfomi

2015 - AMERICAN JOURNAL OF HEMATOLOGY

Rossi, G.; Marcheselli, L.; Dondi, A.; Bottelli, C.; Tucci, A.; Luminari, S.; Arcaini, L.; Merli, M.; Pulsoni, A.; Boccomini, C.; Puccini, B.; Micheletti, M.; Martinelli, G.; Rossi, A.; Zilioli, V. R.; Bozzoli, V.; Balzarotti, M.; Bolis, S.; Cabras, M. G.; Federico, M.

Chronic phase chronic myeloid leukemia patients who failed interferon alpha and switched to imatinib: Long-term 9-year follow-up of 134 patients.

2015 - AMERICAN JOURNAL OF HEMATOLOGY

Breccia, M; Latagliata, R; Molica, M; Colafigli, G; Mancini, M; Diverio, D; Tafuri, Agostino; Alimena, Giuliana

Cardiovascular risk assessments in chronic myeloid leukemia allow identification of patients at high risk of cardiovascular events during treatment with nilotinib.

2015 - AMERICAN JOURNAL OF HEMATOLOGY

Breccia, M; Colafigli, G; Molica, M; Alimena, Giuliana

Introducing biological features at diagnosis improves the relapse risk stratification in patients with acute promyelocytic leukemia treated with ATRA and chemotherapy

2015 - AMERICAN JOURNAL OF HEMATOLOGY

Breccia, Massimo; Stefania de Propris, Maria; Molica, Matteo; Colafigli, Gioia; Minotti, Clara; Diverio, Daniela; Latagliata, Roberto; Guarini, Anna; Lo Coco, Francesco; Foa, Roberto